Advertisement
Canada markets close in 2 hours 31 minutes
  • S&P/TSX

    21,646.70
    -9.35 (-0.04%)
     
  • S&P 500

    5,013.60
    -8.61 (-0.17%)
     
  • DOW

    37,737.15
    -16.16 (-0.04%)
     
  • CAD/USD

    0.7259
    -0.0005 (-0.06%)
     
  • CRUDE OIL

    82.99
    +0.30 (+0.36%)
     
  • Bitcoin CAD

    87,306.56
    +3,697.62 (+4.42%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,400.20
    +11.80 (+0.49%)
     
  • RUSSELL 2000

    1,954.13
    +6.18 (+0.32%)
     
  • 10-Yr Bond

    4.6450
    +0.0600 (+1.31%)
     
  • NASDAQ

    15,631.83
    -51.54 (-0.33%)
     
  • VOLATILITY

    18.00
    -0.21 (-1.15%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • CAD/EUR

    0.6815
    +0.0013 (+0.19%)
     

New Strong Sell Stocks for July 28th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Acer Therapeutics ACER is a pharmaceutical company that develops therapies for the treatment of ultra-rare diseases with critical unmet medical needs.The Zacks Consensus Estimate for its current year earnings has been revised 46.4% downward over the last 60 days.

Braskem BAK is the largest petrochemical operations company in Latin America and among the five largest private companies in Brazil. The Zacks Consensus Estimate for its current year earnings has been revised 42.4% downward over the last 60 days.

Central Japan Railway Co. CJPRY is engaged in the railway, transportation and related businesses in Japan. The Zacks Consensus Estimate for its current year earnings has been revised almost 11.1% downward over the last 60 days.

ADVERTISEMENT

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Braskem S.A. (BAK) : Free Stock Analysis Report
 
Acer Therapeutics Inc. (ACER) : Free Stock Analysis Report
 
Central Japan Railway Co. (CJPRY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research